Summit Therapeuticsincis A Biopharmaceutical Company Focused On Oncologydedicated To Discoveringdevelopingand Commercializing Therapies That Benefit Patientsphysicianscaregiversand Societyfounded In 2003 And Headquartered In Miamifloridawith Additional Offices In Menlo Parkcaliforniaand Oxfordukthe Company Is Listed On The Nasdaq Global Market Under The Symbolsmmtthe Company Employs A Comprehensive Approach To Drug Developmentwhich Includes Designing And Executing Clinical Trials And Obtaining Regulatory Approvalssummit Therapeutics Collaborates With Various Institutions To Advance Its Product Pipelinewhich Includes Key Candidates Like Ivonescimaba Bispecific Antibody For Non Small Cell Lung Cancerridinilazole For Cdifficile Infectionsand Treatments For Carbapenem Resistant Enterobacteriaceaecreinfectionswith A Team Of Around 159 Professionalssummit Therapeutics Is Committed To Addressing Serious Unmet Medical Needs And Improving The Quality Of Life For Patients
